HAKLIYIM
/
Trending
New
Siyaset
Spor
Kripto
Espor
İran
Finans
Jeopolitik
Bilim ve Teknoloji
Kültür
Ekonomi
Bahsetmeler
Seçimler
More
All
355
AI
96
Elon Musk
36
Elma
17
SpaceX
33
OpenAI
34
Research
1
FDA
21
Büyük Teknoloji
152
TikTok
0
Bilim ve Teknoloji
Bilim ve Teknoloji
All
AI
Elon Musk
Elma
SpaceX
OpenAI
Research
FDA
Büyük Teknoloji
TikTok
FDA approves Retatrutide this year?
3%
chance
Yes
No
$579k Vol.
FDA approves skin cancer vaccine by...?
December 31, 2027
68%
Yes
68%
No
32%
June 30, 2027
36%
Yes
36%
No
64%
$44k Vol.
Skin cancer vaccine BLA submitted by June 30, 2027?
88%
chance
Yes
No
$38k Vol.
Who will Trump announce as next FDA commissioner?
Sara Brenner
1%
Yes
1%
No
99%
Stephen Hahn
1%
Yes
1%
No
99%
Kyle Diamantas
0%
Yes
0%
No
100%
No announcement by December 31
0%
Yes
0%
No
100%
Grace Graham
0%
Yes
0%
No
100%
Brett Giroir
0%
Yes
0%
No
100%
$35k Vol.
FDA approves Sanofi’s Subcutaneous Sarclisa?
0%
chance
Yes
No
$8k Vol.
FDA approves Outlook Therapeutics' ONS-5010?
99%
chance
Yes
No
$6k Vol.
FDA approves Arcalyst technology transfer?
9%
chance
Yes
No
$6k Vol.
FDA approves Arcutis' Zoryve cream?
89%
chance
Yes
No
$4k Vol.
FDA approves Corcept Therapeutics' Relacorilant?
100%
chance
Yes
No
$4k Vol.
FDA approves Sanofi's Subcutaneous Sarclisa?
66%
chance
Yes
No
$4k Vol.
FDA approves Unicycive's Oxylanthanum carbonate?
82%
chance
Yes
No
$4k Vol.
FDA moves BPC-157 to Category 1 by…?
December 31, 2026
46%
Yes
46%
No
54%
August 31, 2026
4%
Yes
4%
No
96%
$3k Vol.
FDA approves Ionis' Olezarsen?
88%
chance
Yes
No
$2k Vol.
FDA approves Camurus' Oclaiz?
92%
chance
Yes
No
$2k Vol.
FDA approves AstraZeneca's Camizestrant?
4%
chance
Yes
No
$2k Vol.
FDA approves MannKind's FUROSCIX ReadyFlow Autoinjector?
100%
chance
Yes
No
$778 Vol.
FDA approves Daiichi Sankyo & AstraZeneca's Enhertu?
79%
chance
Yes
No
$687 Vol.
FDA approves Celcuity's Gedatolisib?
100%
chance
Yes
No
$320 Vol.
FDA approves Merck's Welireg + Keytruda or Keytruda Qlex?
81%
chance
Yes
No
$274 Vol.
FDA approves Otsuka's Centanafadine?
39%
chance
Yes
No
$199 Vol.
FDA approves Elevar Therapeutics' Rivoceranib + camrelizumab?
50%
chance
Yes
No
$20 Vol.
Home
Search
New
More